Dose optimization of tacrolimus with therapeutic drug monitoring and CYP3A5 polymorphism in patients with myasthenia gravis (English)
- New search for: Chen, D.
- New search for: Hou, S.
- New search for: Zhao, M.
- New search for: Sun, X.
- New search for: Zhang, H.
- New search for: Yang, L.
- New search for: Chen, D.
- New search for: Hou, S.
- New search for: Zhao, M.
- New search for: Sun, X.
- New search for: Zhang, H.
- New search for: Yang, L.
In:
European Journal of Neurology
;
25
, 8
;
1049-e80
;
2018
- Article (Journal) / Electronic Resource
-
Title:Dose optimization of tacrolimus with therapeutic drug monitoring and CYP3A5 polymorphism in patients with myasthenia gravis
-
Contributors:
-
Published in:European Journal of Neurology ; 25, 8 ; 1049-e80
-
Publisher:
-
Publication date:2018-08-01
-
Size:7 pages
-
ISSN:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:English
-
Keywords:
-
Source:
Table of contents – Volume 25, Issue 8
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1003
-
Relapsing acute disseminated encephalomyelitis followed by optic neuritis in children; a clinical entity associated with anti‐MOG antibodyBrilot, F. et al. | 2018
- 1005
-
Early management of medication‐overuse headache – to remove or to add medication?Lundqvist, C. et al. | 2018
- 1007
-
Hypertension and the acute phase of intracerebral haemorrhage: more evidence of the ‘silent killer’Arboix, A. et al. | 2018
- 1009
-
Role of chronic kidney disease and atrial fibrillation in outcomes of patients with ischemic strokeKhan, A. A. / Lip, G. Y. H. et al. | 2018
- 1011
-
Syndrome and outcome of antibody‐negative limbic encephalitisGraus, F. / Escudero, D. / Oleaga, L. / Bruna, J. / Villarejo‐Galende, A. / Ballabriga, J. / Barceló, M. I. / Gilo, F. / Popkirov, S. / Stourac, P. et al. | 2018
- 1017
-
Non‐invasive brain stimulation for fine motor improvement after stroke: a meta‐analysisO'Brien, A. T. / Bertolucci, F. / Torrealba‐Acosta, G. / Huerta, R. / Fregni, F. / Thibaut, A. et al. | 2018
- 1027
-
Early management of patients with medication‐overuse headache: results from a multicentre clinical studyCorbelli, I. / Sarchielli, P. / Eusebi, P. / Cupini, L. M. / Caproni, S. / Calabresi, P. / SAMOHA Study Group et al. | 2018
- 1034
-
Blood pressure levels in the acute phase after intracerebral hemorrhage are associated with mortality in young adultsMustanoja, S. / Putaala, J. / Koivunen, R.‐J. / Surakka, I. / Tatlisumak, T. et al. | 2018
- 1041
-
Association between impaired renal function and stroke outcome in patients with versus without atrial fibrillationPan, Y. / Jing, J. / Chen, W. / Wang, Y. / He, Y. et al. | 2018
- 1049
-
Dose optimization of tacrolimus with therapeutic drug monitoring and CYP3A5 polymorphism in patients with myasthenia gravisChen, D. / Hou, S. / Zhao, M. / Sun, X. / Zhang, H. / Yang, L. et al. | 2018
- 1055
-
MLC901 (NeuroAiD II™) for cognition after traumatic brain injury: a pilot randomized clinical trialTheadom, A. / Barker‐Collo, S. / Jones, K. M. / Parmar, P. / Bhattacharjee, R. / Feigin, V. L. et al. | 2018
- 1063
-
Pregnancy planning and outcomes in patients with multiple sclerosis after mitoxantrone therapy: a monocentre assessmentFrau, J. / Coghe, G. / Casanova, P. / Sardu, C. / Lorefice, L. / Fenu, G. / Marrosu, M. G. / Cocco, E. et al. | 2018
- 1069
-
Prospective real‐world analysis of OnabotulinumtoxinA in chronic migraine post‐National Institute for Health and Care Excellence UK technology appraisalAndreou, A. P. / Trimboli, M. / Al‐Kaisy, A. / Murphy, M. / Palmisani, S. / Fenech, C. / Smith, T. / Lambru, G. et al. | 2018
- 1076
-
Humoral immunity response to human endogenous retroviruses K/W differentiates between amyotrophic lateral sclerosis and other neurological diseasesArru, G. / Mameli, G. / Deiana, G. A. / Rassu, A. L. / Piredda, R. / Sechi, E. / Caggiu, E. / Bo, M. / Nako, E. / Urso, D. et al. | 2018
- 1086
-
Brainstem leukoaraiosis independently predicts poor outcome after ischemic strokeGiralt‐Steinhauer, E. / Medrano, S. / Soriano‐Tárraga, C. / Mola‐Caminal, M. / Rasal, R. / Cuadrado‐Godia, E. / Rodríguez‐Campello, A. / Ois, A. / Capellades, J. / Jimenez‐Conde, J. et al. | 2018
- 1093
-
Application of the DAWN clinical imaging mismatch and DEFUSE 3 selection criteria: benefit seems similar but restrictive volume cut‐offs might omit potential respondersDucroux, C. / Khoury, N. / Lecler, A. / Blanc, R. / Chetrit, A. / Redjem, H. / Ciccio, G. / Smajda, S. / Escalard, S. / Desilles, J.‐P. et al. | 2018
- 1100
-
Blink reflex recovery cycle to differentiate progressive supranuclear palsy from corticobasal syndromeSciacca, G. / Nicoletti, A. / Mostile, G. / Luca, A. / Raciti, L. / Dibilio, V. / Drago, F. / Salomone, S. / Zappia, M. et al. | 2018
- e86
-
Blood–brain barrier permeability in a patient with Labrune syndrome due to SNORD118 mutationsTaglia, I. / Di Donato, I. / De Stefano, N. / Bianchi, S. / Galluzzi, P. / Federico, A. / Dotti, M. T. et al. | 2018
- e88
-
Blood−brain barrier permeability in a patient with Labrune syndrome due to SNORD118 mutations: would this be the mechanism for progressive worsening?Pessoa, A. et al. | 2018
- e91
-
A novel prion protein gene‐truncating mutation causing autonomic neuropathy and diarrheaBommarito, G. / Cellerino, M. / Prada, V. / Venturi, C. / Capellari, S. / Cortelli, P. / Mancardi, G. L. / Parchi, P. / Schenone, A. et al. | 2018
- e93
-
Brain comorbidities in normal pressure hydrocephalus and their impact on the cerebrospinal fluid tap test?Onder, H. et al. | 2018
- e94
-
Brain comorbidities in normal pressure hydrocephalusAllali, G. / Assal, F. et al. | 2018
- e95
-
Functional eyelid opening apraxia: a kinematic studyHophing, L. / Bologna, M. / Berardelli, A. / Fasano, A. et al. | 2018